E Fund Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
3,598
+233
+7% +$131K 0.04% 161
2026
Q1
$1.89M Buy
+3,365
New +$2.16M 0.06% 153
2025
Q2
$1.39M Sell
2,594
-489
-16% -$234K 0.07% 136
2025
Q1
$1.29M Buy
3,083
+1,016
+49% +$441K 0.06% 146
2024
Q4
$855K Sell
2,067
-367
-15% -$161K 0.04% 166
2024
Q3
$1.23M Buy
2,434
+1,101
+83% +$535K 0.06% 127
2024
Q2
$649K Buy
1,333
+12
+0.9% +$6.02K 0.04% 154
2024
Q1
$713K Buy
1,321
+57
+5% +$31.1K 0.04% 133
2023
Q4
$702K Buy
1,264
+101
+9% +$47.4K 0.04% 112
2023
Q3
$508K Buy
1,163
+178
+18% +$88.8K 0.04% 120
2023
Q2
$495K Sell
985
-121
-11% -$58K 0.04% 114
2023
Q1
$553K Sell
1,106
-97
-8% -$46.4K 0.04% 118
2022
Q4
$491K Sell
1,203
-161
-12% -$62.5K 0.04% 132
2022
Q3
$444K Buy
1,364
+105
+8% +$38.6K 0.04% 151
2022
Q2
$442K Buy
1,259
+69
+6% +$28.1K 0.04% 167
2022
Q1
$651K Sell
1,190
-8
-0.7% -$4.21K 0.02% 106
2021
Q4
$789K Buy
1,198
+17
+1% +$10.7K 0.03% 123
2021
Q3
$734K Buy
+1,181
New +$794K 0.03% 108
2021
Q1
$587K Buy
+1,200
New +$601K 0.05% 119

Other funds holding IDXX

E Fund Management's IDXX Position: Q2 2026 in Review

E Fund Management increased its Idexx Laboratories (IDXX) stake by 6.9% in Q2 2026, buying an estimated $131K and bringing the position to 3,598 shares worth $1.89M. The position accounts for 0.04% of the portfolio, ranked #161.

E Fund Management first reported a position in IDXX in Q1 2021 and has held it in 19 quarters since. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • E Fund Management held 3,598 shares of Idexx Laboratories worth $1.89M as of Q2 2026.
  • E Fund Management bought 233 Idexx Laboratories shares in Q2 2026, an estimated $131K.
  • Idexx Laboratories made up 0.04% of E Fund Management's portfolio in Q2 2026, its #161 holding.
  • E Fund Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 19 quarters since.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.